Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Assessment of fetal scalp oxygen saturation determination in the sheep by transmission pulse oximetry

Article Abstract:

The Spiral O(sub 2)CTG pulse oximeter from Respironics Inc. appears to be effective in monitoring fetal oxygen levels, according to a study in sheep. The device is placed directly on the fetal scalp and gave readings comparable to those from devices that measure oxygen levels in blood.

Author: Ross, Michael G., Nijland, Mark J.M., Shankar, Uday, Iyer, Vijay
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2000
Evaluation, Product information, Equipment and supplies, Measurement, Oxygen, Oxygen in the body, Fetal monitoring, RESP, Blood gases, Oximetry, Respironics Georgia Inc., HDTC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Regulation of hypothalamic arginine vasopressin messenger ribonucleic acid and pituitary arginine vasopressin content in fetal sheep: effects of acute tonicity alterations and fetal maturation

Article Abstract:

The significantly inverse relationship between hypothalamic arginine vasopressin messenger ribonucleic acid and pituitary arginine vasopressin content in the sheep fetus may indicate a functioning feedback loop in terms of maintaining fluid homeostasis. Researchers observed the effects of severe maternal dehydration and salt depletion on fetal development in the context of arginine vasopressin status.

Author: Ervin, M. Gore, Ross, Michael G., Nijland, Mark J.M., Zhao, Xiaohui
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
Models, Maternal-fetal exchange, Fetus, Growth, Physiological regulation, Dehydration (Physiology), Fetal development, Body fluids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Maternal 1-deamino-8-D-arginine-vasopressin-induced sequential decreases in plasma sodium concentration: ovine fetal renal responses

Article Abstract:

The drug 1-deamino-8-D-arginine-vasopressin (DDAVP) might be useful in treating oligohydramnios. Oligohydramnios is decreased amniotic fluid and can have disastrous consequences for the fetus. Researchers gave seven pregnant sheep DDAVP, which caused their blood sodium levels to drop. Their fetuses experienced a similar drop in blood sodium and began to excrete more urine. Ultimately, this would lead to increased amniotic fluid. A 53% increase in fetal urine production could result from a small drop in sodium levels of 5 to 7 milli-equivalents per liter.

Author: Ross, Michael G., Nijland, Mark J.M., Curran, Mark, Roberts, Todd J.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1999
Research, Hyponatremia, Oligohydramnios

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Vasopressin, Vasopressins
Similar abstracts:
  • Abstracts: Localization of messenger ribonucleic acid for adrenomedullin and adrenomedullin receptor in the human placenta in normal pregnancies and pregnancies complicated by oligohydramnios
  • Abstracts: Relation between damage to the placenta and the fetal brain after late-gestation placental embolization and fetal growth restriction in sheep
  • Abstracts: Association of stress during delivery with increased numbers of nucleated cells nad hematopoietic progenitor cells in umbilical cord blood
  • Abstracts: Magnesium sulfate induces translocation of protein kinase C isoenzymes alpha and delta in myometrial cells from pregnant women
  • Abstracts: Assocation of ABO incompatibility with elevation of nucleated red blood cell counts in term neonates. Nucleated red blood cells in cord blood of singleton term neonates
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.